PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue
API Holdings has pulled its 2021-filed Rs 6,250 crore IPO papers from SEBI and is weighing a rights issue to existing backers including Prosus, TPG and Temasek. The retreat reflects cooling appetite for new-age listings and follows the Rs 4,546 crore Thyrocare buy that stretched the balance sheet.
API Holdings pulls Rs 6,250 cr DRHP from SEBI, weighs rights issue to Prosus, TPG and Temasek as new-age listing appetite cools.
Moneycontrol · News Web · 5/26/2026, 9:46:12 PM · Ask about this →